GBA1 and Parkinson disease: Similarly, inflammatory mediators are increased in the plasma from GBA1-PD patients [207], and levels of interleukin (IL)-8, monocyte chemoattractant protein-1, and macrophage inflammatory protein-1 alpha are significantly associated with the GBA1 mutation genotype [208].